Compounds > tenofovir
Page last updated: 2024-08-24

tenofovir and 2'-deoxyadenosine triphosphate

tenofovir has been researched along with 2'-deoxyadenosine triphosphate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, KA; Suo, Z1
Babusis, D; Durand-Gasselin, L; Flaherty, JF; Hawkins, T; Ray, AS; Reddy, YS; Veikley, W1
Aung, W; Cong, ME; García-Lerma, JG; Hanson, DL; Heneine, W; Holder, A; Kersh, E; Kuklenyik, S; Lee, WA; Lin, CY; Luo, W; Martin, A; Mitchell, J; Pau, CP; Ray, AS; Rooney, JF; Youngpairoj, AS; Zheng, Q1
Anderson, KS; Becnel, KD; Frey, KM; Garforth, SJ; Kim, J; Li, Y; Liotta, DC; Prasad, VR; Schinazi, RF; Wang, L1
Anderson, PL; Bushman, LR; Castillo-Mancilla, JR; Chen, X; MaWhinney, S; McAllister, KB; Seifert, SM; Zheng, JH1

Trials

2 trial(s) available for tenofovir and 2'-deoxyadenosine triphosphate

ArticleYear
Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Adenine; Adult; Aged; Anti-HIV Agents; Chromatography, Liquid; Deoxyadenine Nucleotides; Deoxyguanine Nucleotides; Didanosine; Dideoxynucleotides; Female; HIV Infections; Humans; Male; Middle Aged; Nucleotides; Organophosphonates; Tandem Mass Spectrometry; Tenofovir; Young Adult

2011
Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9

    Topics: Adult; Anti-HIV Agents; Case-Control Studies; Deoxyadenine Nucleotides; Deoxycytosine Nucleotides; Deoxyguanine Nucleotides; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Linear Models; Male; Tenofovir; Thymine Nucleotides

2016

Other Studies

3 other study(ies) available for tenofovir and 2'-deoxyadenosine triphosphate

ArticleYear
Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
    The Journal of biological chemistry, 1998, Oct-16, Volume: 273, Issue:42

    Topics: Adenine; Animals; Anti-HIV Agents; Deoxyadenine Nucleotides; Dideoxynucleotides; DNA Polymerase beta; HIV Reverse Transcriptase; Kinetics; Models, Chemical; Organophosphonates; Organophosphorus Compounds; Rats; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir

1998
Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors.
    Journal of virology, 2011, Volume: 85, Issue:13

    Topics: Adenine; Animals; Anti-HIV Agents; Chemoprevention; Deoxyadenine Nucleotides; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lymphocytes; Lymphoid Tissue; Macaca; Organophosphonates; Prodrugs; Rectum; Reverse Transcriptase Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Substrate Specificity; Tenofovir

2011
Pre-steady state kinetic analysis of cyclobutyl derivatives of 2'-deoxyadenosine 5'-triphosphate as inhibitors of HIV-1 reverse transcriptase.
    Bioorganic & medicinal chemistry letters, 2012, Jun-15, Volume: 22, Issue:12

    Topics: Adenine; Anti-HIV Agents; Cyclobutanes; Deoxyadenine Nucleotides; DNA Primers; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Mutation; Nucleic Acid Amplification Techniques; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir

2012